Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2012 Jan 17;61(2):281–291. doi: 10.2337/db11-0649

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2012 by the American Diabetes Association.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

PMC Copyright notice

FIG. 1. — mRNA expression of GPR55 (A), CB1 (B), and CB2 (C) in VAT obtained from lean and obese subjects in cohort 1. mRNA expression of GPR55 (D) and CB1 (E) in SAT obtained from lean and obese subjects in cohort 1. mRNA expression of GPR55 (F) in VAT obtained from lean and obese subjects in cohort 2. Protein levels of GPR55 (G) in VAT obtained from lean and obese subjects in cohort 2. Dividing lines indicate splicings in the figure. Levels of GPR55 in the three different groups of obese patients (H). mRNA expression of GPR55 in the visceral and subcutaneous fat from the same obese patients (I). Protein levels of GPR55 in the visceral and subcutaneous fat from the same obese patients (J). mRNA expression of CB1 in the visceral and subcutaneous fat from the same obese patients (K). Obese subjects were subclassified as NGT, IGT, and type 2 diabetic. The relative amounts of mRNA were normalized to the value of NGT. T2D, type 2 diabetes; Visc, visceral; Subc, subcutaneous. #P < 0.05, ##P < 0.01, ###P < 0.001 vs. lean subjects; *P < 0.05, **P < 0.01 vs. NGT.